
After decades with few advancements in treatment, IMFINZI is the first FDA-approved immunotherapy for limited-stage small cell lung cancer (LS-SCLC) following cCRT (platinum-based chemotherapy and radiation therapy given together).
complete up to 4 cycles of platinum-based chemotherapy and radiation therapy given together. This is known as chemoradiation therapy (cCRT)
receive treatment with IMFINZI every 4 weeks for up to 2 years. Your doctor will determine how often and how long you will receive IMFINZI.
You will stop receiving IMFINZI if your disease progresses or if your side effects are too difficult to manage.
IMFINZI is given:
Ask your doctor how long you should stay on IMFINZI. Every person is different. Your doctor will decide how long you will receive IMFINZI and how many treatments you need. He or she will monitor you regularly for possible side effects, and to see if IMFINZI is working to keep your cancer from growing or spreading.
IMFINZI is expanding treatment options for LS-SCLC
IMFINZI is one of few treatment advances for LS-SCLC in 3 decades. Talk to your doctor about how a new treatment option may help treat LS-SCLC after cCRT.
How do I prepare for my treatment?
During treatment, your comfort matters. A little planning can go a long way to help improve your treatment experience. Here are a few suggestions to help get you ready for treatment day:
Show up early so you don’t feel rushed
Eat a small meal
Drink plenty of water to stay hydrated
Dress comfortably in loose-fitting clothes
Write down any questions you may have for your care team
Here are some things to bring that may be useful on treatment days:
Identification/
insurance card
List of medications you are taking
Snacks in case you get hungry
Water bottle to help you stay hydrated
Lip balm, lotion, and hard candy to soothe dry skin and lips
Sweater or blanket in case you get cold
Things to keep you entertained, like reading materials, mobile devices (phone, laptop, tablet), and a charger for your devices
Be sure to notify your doctor if you experience any infusion reactions
Remember to schedule your next appointment before leaving the treatment center
If possible, take it easy for the rest of the day
Contact your healthcare team right away if you develop any new or worsening signs or symptoms
Helpful tip: Keep a journal to write down how you are feeling and any questions you may have for your doctor.
How should I talk to my doctor about limited-stage small cell lung cancer?
Having an open and honest conversation about SCLC is key. If you or someone you know has LS-SCLC, and is ready to take the next step, read through the questions below to help prepare for your appointment.
About LS-SCLC
Treating your LS-SCLC
Taking care of yourself
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called SCLC.
It is not known if IMFINZI is safe and effective in children.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI if you have severe side effects
Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you:
Females who are able to become pregnant:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of IMFINZI when used alone in adults with limited-stage small cell lung cancer (LS-SCLC) include inflammation in the lungs and feeling tired or weak.
The most common side effects of IMFINZI when used with etoposide and either carboplatin or cisplatin in adults with extensive-stage small cell lung cancer (ES-SCLC) include nausea, hair loss, and feeling tired or weak.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may
report side
effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Call your doctor for medical advice about side effects. You may
report side
effects related to AstraZeneca products. If you prefer to
report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called small cell lung cancer (SCLC).
It is not known if IMFINZI is safe and effective in children.
Please see Full Prescribing Information including Medication Guide for IMFINZI.
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to attack normal organs and tissues in...
IMFINZI is a medicine that may treat...
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called SCLC.
IMFINZI is a medicine that may treat certain cancers by work...
IMFINZI is a medicine that may treat certain cancers by working with your immune system. IMFINZI can cause your immune system to...